Linked Data API

Show Search Form

Search Results

1688051
registered interest false more like this
date less than 2024-02-06more like thismore than 2024-02-06
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Osteoporosis: Screening more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United States to give earlier diagnosis of osteoporosis. more like this
tabling member printed
Baroness Merron more like this
uin HL2250 remove filter
answer
answer
is ministerial correction false more like this
date of answer less than 2024-02-13more like thismore than 2024-02-13
answer text <p>OsteoSight is not a registered product with the Medicines and Healthcare Products Regulatory Agency, therefore the Government is not currently considering the use of this technology. However, we will continue to explore areas where artificial intelligence can be deployed in health and care to support clinicians, transform patient experience and improve outcomes.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-02-13T12:57:41.407Zmore like thismore than 2024-02-13T12:57:41.407Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
347
label Biography information for Baroness Merron more like this